SP769TREATMENT WITH(PLASMAPHERESIS,IMMUNOGLOBULINS AND RITUXIMAB) WITH OR WITHOUT BORTEZOMIB FOR CHRONIC ACTIVE ANTIBODY MEDIATED REJECTION IN KIDNEY TRANSPLANTATION: A PILOT RCT | Zendy

AI Assistant Blog Pricing

SP769TREATMENT WITH(PLASMAPHERESIS,IMMUNOGLOBULINS AND RITUXIMAB) WITH OR WITHOUT BORTEZOMIB FOR CHRONIC ACTIVE ANTIBODY MEDIATED REJECTION IN KIDNEY TRANSPLANTATION: A PILOT RCT

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.